The influence of BIBW22BS, a dipyridamole derivative, on the antiproliferative effects of 5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (13-14) , 2313-2319
- https://doi.org/10.1016/0959-8049(95)00440-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Biochemical modulation of ‘classical’ multidrug resistance by BIBW22BS, a potent derivative of dipyridamoleAnnals of Oncology, 1994
- Dipyridamole modulates multidrug resistance and intracellular as well as nuclear levels of doxorubicin in B16 melanoma cellsInternational Journal of Cancer, 1994
- The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancerBritish Journal of Cancer, 1993
- Production of Monoclonal Antibodies to Squamous Cell Carcinoma AntigensJAMA Otolaryngology–Head & Neck Surgery, 1990
- Modulation of dipyridamole action by α1acid glycoproteinBiochemical Pharmacology, 1989
- Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell lineBiochemical Pharmacology, 1989
- Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistanceInternational Journal of Cancer, 1988
- Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamoleBiochemical Pharmacology, 1987
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Dipyridamole kineticsClinical Pharmacology & Therapeutics, 1982